Fast and direct permeation of drug molecules is crucial
for effective
biotherapeutics. Inspired by a recent finding that fluorous compounds
disrupt the hydrogen-bonded network of water, we developed fluoro-crown
ether phosphate CyclicFP-X. This compound acts as a fast
cell-permeating agent, enabling direct delivery of various bioactive
cargos (X) into cancer cells without endocytic entrapment. In contrast,
its nonfluorinated cyclic analog (CyclicP-X) failed to
achieve cellular internalization. Although the acyclic fluorous analog AcyclicFP-X was internalized, this process occurred slowly
owing to the involvement of an endocytic trapping pathway. Designed
with a high fluorine density, CyclicFP-X exhibits compactness,
polarity, and high-water solubility, facilitating lipid vesicle fusion
by disrupting their hydration layers. Raman spectroscopy confirmed
the generation of dangling −OH bonds upon addition of CyclicFP-OH to water. Furthermore, conjugating CyclicFP-X with fluorouracil (FU, an anticancer drug) via a reductively
cleavable disulfide linker (CyclicFP-SS-FU) demonstrated
the general utility of fluoro-crown ether phosphate as a potent carrier
for biotherapeutics.